Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Regenerative Medicine Essentials
    • World Stem Cell Summit
    • Exploring Public Policy: Regenerative Medicine and Cell Therapies
    • Congressional Briefings
    • Regenerative Medicine and Stem Cell Action Awards
    • World Stem Cell Summit – CHINA
  • Membership/Donate
    • Membership
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page

Longeveron Aging Frailty Phase 2b Trial

by Kevin McMahon | Jan 21, 2018 | News & Opinions, Science

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...

Aging Frailty with Influenza Vaccine Trial announced by Longeveron

by Kevin McMahon | Jan 21, 2018 | News & Opinions, Science

America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...

Recent Posts

  • Phase I clinical trial shows promise of adipose-derived stem cells in treating lymphedema
  • HCP Busted for Selling Fake Stem Cell Therapy
  • New institute to leverage experts to advance regenerative medicine
  • Karīna Narbute’s Research in Extracellular Vesicles Earns Her Young Investigator Award
  • Retinal cell transplant clears experimental hurdle toward treating blindness
Tweets about @WSCSummit
CC Regenerative Medicine Foundation